节点文献

胺碘酮治疗急性冠脉综合征伴快速房颤临床分析

Intravenous amiodarone for fast atrial fibrillation in patients with acute coronary artery syndrome

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 郭龙枝陈娟

【Author】 GUO Long-zhi,CHEN Juan.The First Henan Rong-kang Hospital.Xinxiang,Henan 453003,China

【机构】 河南第一荣康医院

【摘要】 目的 观察静脉滴注胺碘酮在急性冠状动脉综合征(ACS)伴快速房颤患者的临床疗效。方法 20例ACS患者伴新近发生快速房颤,静脉应用胺碘酮,先静脉注射负荷量后,继以静脉滴注维持观察房颤转复及心室率控制及不良反应。结果 20例患者心率用药后较用药前明显下降(P<0.01)。其中14例患者(70%)在24 h内转为窦性心律,3例用药后出现长R-R间期,3例出现窦性心动过缓,经停药或减药后恢复。结论静脉应用胺碘酮治疗ACS伴快速房颤是有效及安全的。

【Abstract】 Objective To observe the effect of amiodarone to fast atrial fibrillation in patients with acute coronary artery syndrome(ACS).Methods Twenty ACS patients with newly onset fast atrial fibillation were observed.After a load dose,intravenous amiodarone was administered continuously.Efficacy of amiodarone in the reversion of atrial fibrillation and the contro1 of ventricular rate as well as the side effects were observed.Results The ventricular rate after the administration of amiodarone in the 20 patients were respectively,significantly lowered than the rate before the drug was given(P<0.01).Atrial fibrillation was reverted to sinus rhythm with 24 hour in 14 of 20 case(70%).Long R-R intermitment observed in 3 patients,sinus bradycardia was occurred in 3 patients,cardiac rhythm in all the patients’returned to normal after reducing the dose or ceasing the medicine.Conclusion Intravenous amiodarone is effective and safe in the treatment of fast atrial fibrillation in patients with ACS.

【关键词】 冠状动脉疾病心房颤动胺碘酮
【Key words】 Coronary diseaseAtrial fibrillationAmiodarone
  • 【文献出处】 中国实用医药 ,China Practical Medicine , 编辑部邮箱 ,2011年01期
  • 【分类号】R541.4
  • 【被引频次】2
  • 【下载频次】48
节点文献中: 

本文链接的文献网络图示:

本文的引文网络